WAB reported Q2 results on July 22 with the stock already up 2.2% on the day to $263.53, vindicating the call-heavy options positioning that had been building for weeks — but the real question now is whether the $22 billion backlog story translates into upward estimate revisions.
The options market flagged this outcome ahead of time. The put/call ratio collapsed to 0.43 on the day of the print, more than two standard deviations below its 20-day average of 0.69 — the most aggressively call-skewed reading in the past year. That compares with a ratio above 1.0 as recently as mid-June, when sentiment was far more defensive. The swing from puts to calls has been sharp and sustained across the past six weeks, and Tuesday's print confirmed the directional bias. Borrow conditions added nothing to the bear case: availability remains effectively unlimited, with shares-available running at roughly 9,000% of current short interest. Short interest itself crept up 4.4% on the week to 1.82% of the free float — a modest rebuilding, but still far too thin to generate any meaningful squeeze dynamic or signal real conviction on the short side.
The Street debate coming into the print captured two legitimate tensions. Bulls pointed to the $22 billion backlog, international expansion, and digital intelligence initiatives, backed by a cash position capable of funding both organic growth and M&A. Bears highlighted downward EPS revisions across FY25 through FY27 and the risk of a broader industrial slowdown hitting railcar and locomotive demand. Citigroup trimmed its target marginally to $311 on July 13 while holding Buy; JP Morgan raised its Neutral target from $290 to $300 the same day — a sign the Street sees modest upside but little urgency to upgrade. The mean analyst target sits at $304, roughly 15% above Tuesday's close, which is a reasonable buffer but not a screaming discount. The PE has eased about 1.5 turns over the past month to roughly 23x, while EV/EBITDA has drifted up to 16.3x — valuation is neither stretched nor particularly cheap for a high-quality industrial with this kind of backlog visibility. The analyst recommendation differential factor ranks in the 98th percentile, meaning the buy-side skew is unusually high relative to the universe.
One angle worth noting is the CEO's recent activity. Rafael Santana sold shares across multiple tranches on July 6 and 7, totalling around $555,000 at prices between $254 and $264. These are modest in absolute terms — significance scores of 2 out of 10 — and likely reflect a pre-arranged plan rather than a discretionary call. Still, the sales occurred right at current price levels, and the 90-day net insider position is a net sell of roughly $3.8 million. That's not alarming for a stock of this size, but it's worth holding alongside the otherwise bullish setup.
Among correlated peers, the day's industrial tape was broadly positive. CAT gained 3% on the day, TEX jumped nearly 3%, and ALSN added 2.2% — broadly in line with WAB's own move, suggesting the stock tracked sector sentiment rather than breaking out on idiosyncratic earnings momentum. GTES was the day's standout, up over 5%. The next scheduled earnings event is October 21, which gives the market three months to decide whether today's reaction was the start of a re-rating or simply a relief trade.
The watch item from here is whether analyst targets move materially above the current $304 consensus — particularly from the firms holding Neutral ratings — as the backlog delivery story either accelerates or stalls into year-end.
See the live data behind this article on ORTEX.
Open WAB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
